Release 1 (Q2 2018)
Release 2 (Q4 2018)
Release 3 (Q2 2019)
Release 4 (Q4 2019)
Release 5 (Q2 2020)
Attenzione. C'è il rischio che i membri non verificati non siano effettivamente membri del team
$35 000 000
$327 639 958
$52 600 000
$96 400 000
Opportunities:The project is led by a strong team with deep experience in the healthcare industry. They are being advised by respected people in the healthcare and insurance industry. This is going to help Solve Care open doors to companies in the healthcare industry to secure partnerships for the adoption of the product.Solve Care has signed a multi-year contract with a healthcare delivery organization that is responsible for managing care for 250,000 citizens, 5,000 providers, and 200+ facilities in Arizona, US. Should the pilot becomes successful, Solve Care would have a much easier time persuading other companies or government agencies to follow suit.Care.Cards is a platform that allows third party dApps to be hosted on top of it. It is expected that users will be able to use healthcare-related dApps within Care.Cards. This provides substantial potential for the usage of platform.The idea of the project makes sense and would provide significant real world benefits. If successful, the project can save a substantial amount of money in the inefficient healthcare industry.
Concerns:Solve Care has plans to expand globally. However, because the healthcare industry (insurance, doctor, and hospital network, as well as government agencies) is very different in each country (and in the case of the United States, in each state), the expansion plan may not be as quick as the team has projected.The US healthcare industry has proved to be difficult to disrupt with the incumbents resist to changes. The adoption of blockchain technology would eliminate a lot of middlemen and those companies would be against the change. Solve Care is at a fairly early stage and it is unproven that the project could disrupt the US healthcare industry and abroad.
Conclusion:Overall, we like both the short- and long-term potential of this ICO. Our thoughts of the tokens for short term and long term are as follows:For short-term holding:Good. The recent reduction of hard cap is a good move by the team, especially in light of the current market environment. With the strong team and advisor and the ambitious scope of the project, we believe the project can reach hard cap with unmet demand.The crowdsale date of March 31, 2018 is around 1.5 month away, which is longer than most ICOs. This can be both negative and positive – negative in that participants’ funds are locked up for a longer period, positive in that the market environment may be much better then.For long-term holding:Good. The healthcare industry in many countries, including the US, is inefficient and ripe for disruption. If Solve Care is able to fulfill its vision, the potential is substantial. We believe the idea is well thought out and provides significant real world benefits. With the project’s team and advisors, we believe it has a good shot to become successful.
The White Paper is of very high quality with rich visual content. Solve.Care is highly tech and complex product and there are lengthy explanations of how it will work. Information is offered in understandable language and is supported by visuals so it is easy to grasp.
The Solve.Care project is an interesting approach solving the issue of high administrative costs in the health care industry and, if successful, could potentially lower health care costs worldwide.
After reading Solve.Care’s whitepaper and becoming familiar with its core features and functionalities, Solve.Care’s healthcare project looks to be an interesting approach. The project aims to solve the issue of high administrative costs in the health care industry, and it seems to have potential to succeed. However, it is similar to other projects such as ODEM, Requitix, Shping, TV-TWO, Signals, and it has to prove what it claims.
Pros – A strong team led by a CEO with impressive experience; an acquisition of Ukrsoft that has such clients as Delta Airlines, Boeing, and Department of Defense; a new multi-year contract with a solid customer – U.S.-based care delivery network that manages care for 250,000 families, 5,000 providers, and 200+ facilities.Cons – There is a number of competitors on the market of health care services; the platform is planned to launch after ICO; the CEO is a member of so many organizations and businesses that we have doubts he will be able to pay enough attention to the project; there is a lack of details regarding how the funds acquired during ICO will be used.One more project led by a strong team and aiming to make the entire health care system clear, simple, transparent, secure and managed with finger taps.
Questa offerta si basa su informazioni fornite esclusivamente dall'offerente e altre informazioni disponibili pubblicamente. L'evento di vendita o scambio di token non è interamente correlato a ICOholder e ICOholder non ha alcun coinvolgimento in esso (inclusi eventuali supporti tecnici o promozioni). Le vendite di token elencate da persone con cui ICOholder non ha relazioni sono mostrate solo per aiutare i clienti a tenere traccia dell'attività che si svolge all'interno del settore generale dei token. Questa informazione non è intesa come un consiglio su cui dovresti fare affidamento. È necessario ottenere una consulenza professionale o specialistica o eseguire la propria due diligence prima di intraprendere o astenersi da qualsiasi azione sulla base del contenuto del nostro sito. I termini e le condizioni stipulati dai contributori in relazione all'acquisizione di token sono tra loro e l'emittente del token e ICOholder non è il venditore di tali token. ICOholder non ha alcuna responsabilità legale per qualsiasi dichiarazione fatta da terzi in relazione a qualsiasi vendita di token e qualsiasi richiesta di violazione del contratto deve essere fatta anche direttamente contro l'entità emittente dei token qui elencata.
In caso di dubbi sulla natura, sulla proprietà o sulla legalità di questa vendita di token o delle persone coinvolte, contattare [email protected] con informazioni dettagliate sulle tue preoccupazioni.